Another strong quarter for our client Alnylam Pharmaceuticals

May 9

Written By Kimberly Hicks

Kimberly Hicks

Big Moves in AI-Driven Oncology: Pathos Secures Major Backing

Pathos has officially dosed the first patient in its Phase 1b/2a clinical trial evaluating Pocenbrodib.